$1.76
-0.04-2.22%
Ult. Agg.: Oct 13, 4:00 PM
Pulmonx (LUNG) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Pulmonx (LUNG) ha pubblicato l'ultima guidance il luglio 29, 2026 per fiscal year 2026. La società ha previsto un fatturato pari a $90M - $92M per il periodo.
Rispetto alle previsioni precedenti, Pulmonx ha modificato le sue previsioni di fatturato da un intervallo precedente di .
Pulmonx ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il Pulmonx. 18
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.28 | $-0.33 | $-0.39 | $-0.41 |
| Actual | $-0.24 | $-0.33 | $-0.25 | $-0.34 |
| Surprise | +14.3% | 0.00% | +35.9% | +17.1% |
| Revenue | ||||
| Estimate | $22.4M | $20.4M | $21.7M | $20.8M |
| Actual | $22.8M | $20.6M | $22.6M | $21.5M |
| Surprise | +1.76% | +1.10% | +3.98% | +3.36% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.26 | $-0.22 | $-0.28 | $-0.19 |
| Revenue | ||||
| Consensus | $22.0M | $25.3M | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Jul 29, 2026 | $-0.24 | $-0.28 | 14.3 % |
| Q1 | Apr 29, 2026 | $-0.33 | $-0.33 | 0.00 % |
| Q4 | Mar 4, 2026 | $-0.25 | $-0.39 | 35.9 % |
| Q3 | Nov 12, 2025 | $-0.34 | $-0.41 | 17.1 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Jul 29, 2026 | $22.76M | $22.36M | 1.76 % |
| Q1 | Apr 29, 2026 | $20.59M | $20.36M | 1.10 % |
| Q4 | Mar 4, 2026 | $22.60M | $21.73M | 3.98 % |
| Q3 | Nov 12, 2025 | $21.50M | $20.80M | 3.36 % |